|
Physical therapy assessment and diagnosis of lipedema
|
|
Reference
|
Study design
|
Sample
|
Method / intervention
|
Main outcomes
|
Level of evidence
|
| Amato et al.14 |
Validation study |
154 women with lipedema |
QuASiL questionnaire translated, culturally adapted, and validated in Brazil. |
Validated a practical and comprehensible (96.4%) Brazilian Portuguese version of the QuASiL. |
Level 4 – low to moderate |
| Bauer et al.10 |
Descriptive study |
209 women with stage 2 lipedema after tumescent liposuction |
Online questionnaire, assessing symptoms and comorbidities. |
Liposuction reduced pain, swelling, and bruising and improved QoL. |
Level 4 – low to moderate |
| Czerwińska et al.15 |
Scoping review |
10 studies |
Various tools: circumference, volume, US, VAS, SF-36, QuASiL, LEFS, 6MWT. |
Identified and summarized tools used to assess outcomes of conservative lipedema treatment. |
Level 4 – moderate |
| Kruppa et al.16 |
Narrative review / expert consensus |
Literature-based |
Clinical assessment guidelines: history, inspection, palpation, and differential diagnosis. |
Summarized pathophysiology hypotheses and provided diagnostic and treatment recommendations; highlighted absence of biomarkers and limited evidence for therapies. |
Level 5-6 – low |
|
Complete decongestive therapy
|
| Szolnoky et al.17 |
Quasi-experimental study |
21 women with lipedema |
MLD, pneumatic compression, and bandaging. |
Significantly reduced limb volume and decreased capillary fragility. |
Level 3 – moderate |
| Atan and Bahar-Özdemir18 |
RCT |
33 women with severe lipedema |
3 groups: CDT + exercise, pneumatic compression + exercise, and exercise alone. |
All groups improved, but CDT + exercise was superior for limb volume, pain, and physical function. |
Level 2 – high |
| Donahue et al.19 |
Interventional pilot study |
5 women with early-stage lipedema |
9 multimodal physical therapy sessions (CDT, exercise, compression, education) + sodium MRI. |
Pain reduction (VAS), functional improvement (PSFS), QoL improvement (RAND-36), and tissue sodium reduction (inflammation marker). |
Level 3 – moderate |
| Schmeller and Meier-Vollrath21 |
Consensus / guideline |
— |
Clinical recommendations. |
Suggested CDT as initial approach in advanced lipedema. |
Level 6 – consensus |
| Faerber et al.20 |
German S2k guideline |
— |
Normative document. |
Reinforced CDT as a central conservative management strategy. |
Level 6 – guideline/consensus |
| Herbst et al.22 |
U.S. consensus guideline |
— |
Clinical guideline. |
Highlighted CDT benefits for drainage, edema control, pain relief, and tissue integrity. |
Level 6 – consensus |
|
Compression therapy
|
| Czerwińska et al.23 |
Interventional pilot study |
6 women with lipedema |
Compression leggings + exercise program. |
Compression + exercise reduced pain and bruising, maintained or decreased limb circumference, and improved QoL. |
Level 3 – moderate |
| Paling and Macintyre24 |
Cross-sectional survey |
279 women with lipedema |
Structured online questionnaire on symptoms and use of compression garments. |
70% used compression garments; main benefits: support (73%), pain reduction (67%), and mobility improvement (54%); but satisfaction was low due to discomfort and donning difficulty. |
Level 4 – low to moderate |
| Ricolfi et al.25 |
Observational pilot study |
29 women with type III lipedema |
Micromassage compression leggings + moderate physical activity. |
Improved spontaneous and evoked pain, reduced limb volume and subcutaneous adipose tissue thickness, and improved skin texture. |
Level 3 – moderate |
|
Motor and musculoskeletal physical therapy
|
| van Esch-Smeenge et al.26 |
Comparative cross-sectional study |
44 women (22 with lipedema, 22 with obesity) |
Muscle strength (MicroFET™) and 6MWT. |
Women with lipedema showed significantly lower quadriceps strength and a trend toward reduced functional capacity. |
Level 3 – moderate |
| Esmer et al.27 |
Systematic review |
10 studies |
Exercise programs (kinesiotherapy, aerobic exercise, resistance, and hydrotherapy). |
Structured exercise improved muscle function, reduced pain, and enhanced QoL. |
Level 1-2 – high |
| Annunziata et al.28 |
Expert consensus |
Review and expert recommendations |
International consensus document. |
Regular physical activity benefited patients with lipedema by improving mitochondrial function and lymphatic circulation and by reducing systemic inflammation. |
Level 6 – consensus/guideline |
|
Manual therapy
|
| Herbst et al.29 |
Prospective pilot study, single arm |
7 women with lipedema |
12 90-min sessions of SAT therapy over 4 weeks. |
Significantly reduced leg volume, skinfold thickness, pain, and tissue fibrosis; improved LEFS score and SAT structure. |
Level 4 – low to moderate |
| Ibarra et al.30 |
Prospective pilot study, single arm |
6 women with lipedema and 1 with Dercum’s disease |
12 90-min sessions of SAT therapy over 4 weeks. |
Significantly reduced leg fat mass (DXA), leg volume, and tissue edema; improved tissue structure and fascial reorganization (US); no significant change in pain (VAS). |
Level 4 – low to moderate |
|
Shock wave therapy
|
|
| Siems et al.31 |
Quasi-experimental study |
26 women with lipedema and/or cellulite |
Pneumatic ESWT combined with CDT, 6 sessions over 2 weeks. |
Reduced oxidative stress (↓MDA, ↓carbonyls); improved skin elasticity and biomechanical properties. |
Level 3 – moderate |
| Michelini et al.32 |
Observational pilot study |
15 women with stage 2 lipedema (types II, III, and V) |
8 sessions of ESWT (defocused + radial) combined with mesotherapy (Lymdiaral®), kinesio taping, and compression between sessions. |
Reduced pain (NRS), circumference, and adipose tissue thickness; improved elasticity, US pattern, and QoL. |
Level 4 – low to moderate |
|
Photobiomodulation
|
| Baxter et al.33 |
RCT |
17 women with breast cancer-related lymphedema |
PBM (980/810 nm, 6 J/cm2, 12 sessions over 6 weeks) + conventional therapy vs. conventional therapy alone. |
High adherence (>88%), no severe adverse events; no significant difference in limb volume or circumference, but a trend toward symptom and psychological improvement in the PBM group. |
Level 2 – moderate |
| Chen et al.34 |
Systematic review and meta-analysis of RCTs |
316 patients with post-mastectomy lymphedema (9 RCTs) |
PBM (650/1000 nm, 1.5-6 J/cm2) vs. sham laser or conventional treatment. |
Slight improvement in limb circumference and volume, not statistically significant; moderate to high heterogeneity; no severe adverse events. |
Level 1 – high |
| Chiu et al.35 |
Systematic review and meta-analysis of RCTs |
11 RCTs (breast cancer-related lymphedema) |
PBM/LLLT (650/1000 nm, 1.5-6 J/cm2, 8-26 sessions, 2-3 ×/week) vs. sham or conventional therapy. |
PBM reduced limb swelling and improved QoL; best results with axillary application, 3 sessions/week, 1.5-2 J/cm2, and >15 sessions; no severe adverse events. |
Level 1 – high |
| Smoot et al.36 |
Systematic review and meta-analysis |
8 RCTs (160 patients with lymphedema) |
LLLT vs. placebo or MLD alone. |
Significant improvement in limb volume, edema, pain, and function; greater effect when combined with compression. |
Level 1 – high |
|
Intermittent pneumatic compression
|
| Szolnoky et al.37 |
Quasi-experimental controlled pilot study |
38 women with lipedema (19 intervention, 19 control) |
CDT (MLD, compression, skin care, exercise) combined with IPC (30 min/day for 5 days). |
Significant reduction in limb volume (≈ 5.6%) and pain intensity across all scales compared with control; no adverse events reported. |
Level 3 – moderate |
| Wright et al.38 |
RCT |
26 women with lipedema and secondary lymphedema |
Pneumatic compression device + conservative care (compression stockings, MLD, education) vs. conservative care alone. |
IPC promoted a 2-fold greater volume reduction compared with compression stockings alone. |
Level 2 – moderate to high |
| Herbst et al.39 |
RCT |
46 women with stage II lipedema |
Home-based IPC group (30 days) vs. control group (compression stockings). |
Significant reductions in left leg volume, total body water, extracellular and intracellular fluids, and subcutaneous tissue thickness; improvements in pain, edema, bruising, and QoL. |
Level 1 – high |
|
Mechanical vibrotherapy
|
| Schneider40 |
Randomized pragmatic clinical trial |
30 women with lipedema |
MLD alone vs. MLD combined with low-frequency vibrotherapy (15-42 Hz, 6 sessions, 30 min each). |
Significant reduction in circumference in the ankle, calf, and thigh; improved QoL and feeling of lightness in the legs. |
Level 1 – high |